Neurodyn Inc. announced today that one of its key patents (Sterol Glucosides Toxins) will be issued in the US on July 30th, 2013. The lead inventor on this patent is Dr. Chris Shaw, University of British Columbia.
Neurodyn Inc. Secures Patent for Diagnostic Technology
This entry was posted in Mertzholdings News. Bookmark the permalink.